Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study
2007

Statin Prescribing in Norway

Sample size: 40143 publication Evidence: moderate

Author Information

Author(s): Hartz Ingeborg, Sakshaug Solveig, Furu Kari, Engeland Anders, Eggen Anne Elise, Njølstad Inger, Skurtveit Svetlana

Primary Institution: Faculty of Health Studies, Hedmark University College

Hypothesis

How do differences in statin use, dosing, and therapy continuity vary across Norwegian counties with different levels of statin consumption?

Conclusion

Variations in statin consumption between counties in Norway are influenced by differences in prevalence of use, treatment intensity, and choice of statin.

Supporting Evidence

  • The high-consumption county had higher prevalence of statin use in all age groups.
  • Atorvastatin and simvastatin were dispensed in 79–87% of all statin users, significantly higher in the high-consumption county.
  • The estimated prescribed daily doses (PDDs) were higher than the defined daily doses (DDDs), up to twice the DDD for atorvastatin.

Takeaway

This study looked at how many people in different parts of Norway take statins and how much they take. It found that more people in some areas take higher doses of statins.

Methodology

Data were retrieved from The Norwegian Prescription Database, including individuals from counties with high, average, and low statin consumption who had at least one statin prescription dispensed during 2004.

Limitations

The study lacks information on statin use in relation to other relevant patient characteristics such as cardiovascular morbidity and risk factors.

Participant Demographics

Participants included individuals from three counties in Norway with varying levels of statin consumption.

Digital Object Identifier (DOI)

10.1186/1472-6904-7-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication